Whoa! Slow down there, you're getting quite excited there. I am
getting lots of weird characters on my screen in your message!
I am also encouraged by your post, even though PRLN continues to drift
downwards (it's still holding relatively well though). If this
call occurs next week, maybe late this week is a good time to buy up
some more PRLN. I'm looking to perhaps get some more if it drifts
down to 3 or so. If it doesn't go that low, and then shoots up,
I won't complain since I'm happy with my current position (about 15%
of my portfolio).
Dr. Babish is correct in that small companies run largely on creativity.
This is great for drug discovery, but, unfortunaterly, clinical
trials don't run on creativity, but cash. Therein is where large
companies have an advantage. Did Dr. Babish mention anything about
collaborations with big Pharma for funding any trials? If PRLN
truly intends to go it alone, and is successful, even for one
product that solely discovers, manufactures, and markets, then I
agree that we should "fasten our seatbelts" for a wild ride.
BTW, is everyone aware that under the "Charts" option on SI one
can chart many stocks (not just the Techs) including PRLN? Check
it out and add some comments there!
If there really are about 15 press releases over the next few
months, it will be interesting to see how many posts pile up here on
the PRLN forum. Maybe I'll have the opportunity to post message
#500 or even #1000?
Rick |
